SlideShare a Scribd company logo
Copyright © 2016 Senad Handanagic, MD,
MSc; WHO Collaborating Centre for HIV
Surveillance, Andrija Stampar School of
Public Health, School of Medicine,
University of Zagreb, Rockefellerova 4,
10 000 Zagreb, Croatia
Phone: +385 1 4590 147;
E-mail: shandanagic@yahoo.com
Senad Handanagica, Ivana Bozicevica, Marta Civljakb, Zoran Dominkovica, Sandra Sevicc, Jelena Barbarica, Tatjana Nemeth Blazicd, Oktavija Dakovic Rodee, Josip Begovace
aWHO Collaborating Centre for HIV Surveillance, Andrija Stampar School of Public Health, School of Medicine, University of Zagreb, bAndrija Stampar School of Public Health,
School of Medicine, University of Zagreb; c
Department of Sociology, Faculty of Humanities and Social Sciences, University of Zagreb, d
Croatian Institute of Public Health, Zagreb;
eUniversity Hospital for Infectious Diseases “Dr Fran Mihaljevic”, School of Medicine, University of Zagreb
Background: There are limited data on HIV
and hepatitis C virus (HCV) epidemiology
among people who inject drugs ( PWID) in
Croatia. This study aims were to provide data
on HIV and HCV prevalence and sexual and
injecting risk behaviours a mong PWID in
Zagreb, Split and Rijeka.
Methods: Using respondent-dr iven sa mpling
(RDS) from November 2014 to February 2015
we recruited a total of 176 PWID in Zagreb,
255 in Rijeka and 399 in Split ( Figure 1).
Participants pr ovided biological specimens for
HIV and HCV testing and completed a
behavioural questionnaire. We used RD S
Analyst statistical package1
to calculate
weighted population estimate s and 95%
confidence intervals (CI) and Gephi2 sof tware
to visualize recruitment chains (Figure 1).
HIV and hepatitisCprevalence,andrelatedriskbehavioursamongpeople who inject
drugsin three citiesinCroatia:Findingsfrom respondent-drivensamplingsurveys
Results: The estimated median age of PWID was
33 years in Zagreb, 34 years in Rijeka and 37 years
in Split. In the month before the surve y, 2.5% of
PWID in Split, 5.6% in Rijeka and 8.0% in Zagreb
reported sharing non- sterile needles and syringes.
Many PWID injected opioid substitution therapy
(OST) in the month before the survey (57.0% in
Zagreb and 57.5% in Split and Rijeka,
respectively). Among PWID who had a casual
sexual partner in the past 12 months (ranging from
39.2% in Split to 44.4% in Rijeka) condom use
was low. A lthough HIV prevalence was low (0.2%
in Rijeka and Zagreb, 0.3% in Split), H CV
antibody prevalence was considerable (29.1% in
Zagreb, 31.5% in Rijeka, 38.3% in Split). HIV and
HCV testing coverage in the past 12 months was
insufficient (Figure 2).
Conclusions: We found a low-level HIV
epidemic and a sizable HCV epide mic among
PWID across all three cities. There is a need to
develop a comprehensive approach to harm
reduction and scale up the coverage with needles
and syringes exchange progra mmes, OST and
HIV and HCV testing services, as well as to
strengthen sexual health interventions due to the
presence of high-risk sexual behaviours.
Figure 2: Weighted population estimates of age, gender, condom use, prevalence of HIV and HCV antibody and
testing rates for HIV and HCV among people who inject drugs (PWID) in three largest Croatian cities, 2015.
Figure 1. Recruitment chains in respondent-driven sampling
(RDS) surveys in three largest Croatian cities, 2015; Green =
HCV negative, Purple = HCV positive, White = unknown test
result, S = initial respondent (seed)
Rijeka; N=255Zagreb; N=176 Split; N=399
1. Handcock MS, Fellows IE, Gile KJ. RDS Analyst: Software for the Analysis of Respondent-Driven Sampling Data, Version 0.51. 2014. Available at http://hpmrg.org
2. Bastian M., Heymann S., Jacomy M. (2009). Gephi: an open source software for exploring and manipulating networks. International AAAI Conference on Weblogs and
Social Media. Available at: https://gephi.org.
73,4%
15,0%
44,3%
6,8%
38,3%
7,0%
74,0%
8,0%
47,9%
20,2%
31,5%
21,5%
80,5%
22,3%
60,9%
13,2%
29,1%
13,5%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Male ≤24 years old Condom used at
last sex with
casual partner
Tested for HIV
in past 12
months and
know the result
HCV antibody Tested for HCV
in past 12
months and
know the result
Split Rijeka Zagreb

More Related Content

What's hot

20151130 SLIDES Capstone SMalvolti
20151130 SLIDES Capstone SMalvolti20151130 SLIDES Capstone SMalvolti
20151130 SLIDES Capstone SMalvolti
Stefano Malvolti
 
Norovirus and food service workers
Norovirus and food service workersNorovirus and food service workers
Norovirus and food service workers
Lindsey Miller
 
NorovirusFoodServiceWorkersLindseyMiller
NorovirusFoodServiceWorkersLindseyMillerNorovirusFoodServiceWorkersLindseyMiller
NorovirusFoodServiceWorkersLindseyMiller
Lindsey Miller
 

What's hot (19)

08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
 
7 katz potential harms of hiv self-testing
7 katz potential harms of hiv self-testing7 katz potential harms of hiv self-testing
7 katz potential harms of hiv self-testing
 
Syphilis Modelling
Syphilis ModellingSyphilis Modelling
Syphilis Modelling
 
CDC HIVST Mtg Seattle WA RM MO
CDC HIVST Mtg Seattle WA RM MOCDC HIVST Mtg Seattle WA RM MO
CDC HIVST Mtg Seattle WA RM MO
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
 
David Wilson: Modelling The Impact of Targeted Syphilis Interventions
David Wilson: Modelling The Impact of Targeted Syphilis InterventionsDavid Wilson: Modelling The Impact of Targeted Syphilis Interventions
David Wilson: Modelling The Impact of Targeted Syphilis Interventions
 
04.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 202004.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 2020
 
Facilitating HIV testing and linkage to care - the UK experience
Facilitating HIV testing and linkage to care - the UK experienceFacilitating HIV testing and linkage to care - the UK experience
Facilitating HIV testing and linkage to care - the UK experience
 
Retension and HIV Testing Christine Khosropour
Retension and HIV Testing Christine KhosropourRetension and HIV Testing Christine Khosropour
Retension and HIV Testing Christine Khosropour
 
Wepdc203
Wepdc203Wepdc203
Wepdc203
 
20151130 SLIDES Capstone SMalvolti
20151130 SLIDES Capstone SMalvolti20151130 SLIDES Capstone SMalvolti
20151130 SLIDES Capstone SMalvolti
 
Syphilis epidemics
Syphilis epidemicsSyphilis epidemics
Syphilis epidemics
 
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
 
Norovirus and food service workers
Norovirus and food service workersNorovirus and food service workers
Norovirus and food service workers
 
Community-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiativeCommunity-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiative
 
Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...
 
NorovirusFoodServiceWorkersLindseyMiller
NorovirusFoodServiceWorkersLindseyMillerNorovirusFoodServiceWorkersLindseyMiller
NorovirusFoodServiceWorkersLindseyMiller
 
HIV Unplugged: Advances in Mobile Health
HIV Unplugged: Advances in Mobile Health HIV Unplugged: Advances in Mobile Health
HIV Unplugged: Advances in Mobile Health
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
 

Viewers also liked

Croatia Power Point
Croatia Power PointCroatia Power Point
Croatia Power Point
guest8e1533
 

Viewers also liked (6)

Pharmacy in croatia - A short overview
Pharmacy in croatia - A short overviewPharmacy in croatia - A short overview
Pharmacy in croatia - A short overview
 
Pharmaceutical pricing in european countries - Valérie Paris - 22-01-15
Pharmaceutical pricing in european countries - Valérie Paris - 22-01-15Pharmaceutical pricing in european countries - Valérie Paris - 22-01-15
Pharmaceutical pricing in european countries - Valérie Paris - 22-01-15
 
Pricing of Medicinal Products and Reimbursement Systems in Europe
Pricing of Medicinal Products and Reimbursement Systems in EuropePricing of Medicinal Products and Reimbursement Systems in Europe
Pricing of Medicinal Products and Reimbursement Systems in Europe
 
Croatia retirement haven
Croatia retirement havenCroatia retirement haven
Croatia retirement haven
 
Croatia
CroatiaCroatia
Croatia
 
Croatia Power Point
Croatia Power PointCroatia Power Point
Croatia Power Point
 

Similar to RDS_PWID_CROATIA_poster_ECCMID_2016

Community based HIV testing @ LGBT centre Zagreb, Croatia - Zoran Dominković
Community based HIV testing @ LGBT centre Zagreb, Croatia - Zoran DominkovićCommunity based HIV testing @ LGBT centre Zagreb, Croatia - Zoran Dominković
Community based HIV testing @ LGBT centre Zagreb, Croatia - Zoran Dominković
ReShape
 
Repeat HIV Testing at Voluntary Testing
Repeat HIV Testing at Voluntary TestingRepeat HIV Testing at Voluntary Testing
Repeat HIV Testing at Voluntary Testing
Marija Berzati
 
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
College of Medicine(University of Malawi)
 
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
College of Medicine(University of Malawi)
 

Similar to RDS_PWID_CROATIA_poster_ECCMID_2016 (20)

Barriers of HIV Prevention through Treatment
Barriers of HIV Prevention through TreatmentBarriers of HIV Prevention through Treatment
Barriers of HIV Prevention through Treatment
 
Community based HIV testing @ LGBT centre Zagreb, Croatia - Zoran Dominković
Community based HIV testing @ LGBT centre Zagreb, Croatia - Zoran DominkovićCommunity based HIV testing @ LGBT centre Zagreb, Croatia - Zoran Dominković
Community based HIV testing @ LGBT centre Zagreb, Croatia - Zoran Dominković
 
Imjh april-2015-5
Imjh april-2015-5Imjh april-2015-5
Imjh april-2015-5
 
135th publication jfmpc- 4th name
135th publication  jfmpc- 4th name135th publication  jfmpc- 4th name
135th publication jfmpc- 4th name
 
135th publication jfmpc- 4th name
135th publication  jfmpc- 4th name135th publication  jfmpc- 4th name
135th publication jfmpc- 4th name
 
33rd Publication -JFMPC- 4th Name.pdf
33rd Publication -JFMPC- 4th Name.pdf33rd Publication -JFMPC- 4th Name.pdf
33rd Publication -JFMPC- 4th Name.pdf
 
Repeat HIV Testing at Voluntary Testing
Repeat HIV Testing at Voluntary TestingRepeat HIV Testing at Voluntary Testing
Repeat HIV Testing at Voluntary Testing
 
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
 
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
Attitudes towards Premarital Testing on Human Immunodeficiency Virus Infectio...
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USA
 
178th publication jfmpc- 7th name
178th publication  jfmpc- 7th name178th publication  jfmpc- 7th name
178th publication jfmpc- 7th name
 
178th publication jfmpc- 7th name
178th publication  jfmpc- 7th name178th publication  jfmpc- 7th name
178th publication jfmpc- 7th name
 
53rd Publication -JFMPC- 7th Name.pdf
53rd Publication -JFMPC- 7th Name.pdf53rd Publication -JFMPC- 7th Name.pdf
53rd Publication -JFMPC- 7th Name.pdf
 
Strategies for HIV Epidemic Control
Strategies for HIV Epidemic ControlStrategies for HIV Epidemic Control
Strategies for HIV Epidemic Control
 
54th Publication -JFMPC- 7th Name.pdf
54th Publication -JFMPC- 7th Name.pdf54th Publication -JFMPC- 7th Name.pdf
54th Publication -JFMPC- 7th Name.pdf
 
179th publication jfmpc- 7th name
179th publication  jfmpc- 7th name179th publication  jfmpc- 7th name
179th publication jfmpc- 7th name
 
179th publication jfmpc- 7th name
179th publication  jfmpc- 7th name179th publication  jfmpc- 7th name
179th publication jfmpc- 7th name
 
Journal.pone.0021528
Journal.pone.0021528Journal.pone.0021528
Journal.pone.0021528
 
07.10.20 | The Use of mHealth to Address the HIV Continuum with Sexual and Ge...
07.10.20 | The Use of mHealth to Address the HIV Continuum with Sexual and Ge...07.10.20 | The Use of mHealth to Address the HIV Continuum with Sexual and Ge...
07.10.20 | The Use of mHealth to Address the HIV Continuum with Sexual and Ge...
 
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...Review from the 24th Conference on Retroviruses and Opportunistic Infections ...
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...
 

RDS_PWID_CROATIA_poster_ECCMID_2016

  • 1. Copyright © 2016 Senad Handanagic, MD, MSc; WHO Collaborating Centre for HIV Surveillance, Andrija Stampar School of Public Health, School of Medicine, University of Zagreb, Rockefellerova 4, 10 000 Zagreb, Croatia Phone: +385 1 4590 147; E-mail: shandanagic@yahoo.com Senad Handanagica, Ivana Bozicevica, Marta Civljakb, Zoran Dominkovica, Sandra Sevicc, Jelena Barbarica, Tatjana Nemeth Blazicd, Oktavija Dakovic Rodee, Josip Begovace aWHO Collaborating Centre for HIV Surveillance, Andrija Stampar School of Public Health, School of Medicine, University of Zagreb, bAndrija Stampar School of Public Health, School of Medicine, University of Zagreb; c Department of Sociology, Faculty of Humanities and Social Sciences, University of Zagreb, d Croatian Institute of Public Health, Zagreb; eUniversity Hospital for Infectious Diseases “Dr Fran Mihaljevic”, School of Medicine, University of Zagreb Background: There are limited data on HIV and hepatitis C virus (HCV) epidemiology among people who inject drugs ( PWID) in Croatia. This study aims were to provide data on HIV and HCV prevalence and sexual and injecting risk behaviours a mong PWID in Zagreb, Split and Rijeka. Methods: Using respondent-dr iven sa mpling (RDS) from November 2014 to February 2015 we recruited a total of 176 PWID in Zagreb, 255 in Rijeka and 399 in Split ( Figure 1). Participants pr ovided biological specimens for HIV and HCV testing and completed a behavioural questionnaire. We used RD S Analyst statistical package1 to calculate weighted population estimate s and 95% confidence intervals (CI) and Gephi2 sof tware to visualize recruitment chains (Figure 1). HIV and hepatitisCprevalence,andrelatedriskbehavioursamongpeople who inject drugsin three citiesinCroatia:Findingsfrom respondent-drivensamplingsurveys Results: The estimated median age of PWID was 33 years in Zagreb, 34 years in Rijeka and 37 years in Split. In the month before the surve y, 2.5% of PWID in Split, 5.6% in Rijeka and 8.0% in Zagreb reported sharing non- sterile needles and syringes. Many PWID injected opioid substitution therapy (OST) in the month before the survey (57.0% in Zagreb and 57.5% in Split and Rijeka, respectively). Among PWID who had a casual sexual partner in the past 12 months (ranging from 39.2% in Split to 44.4% in Rijeka) condom use was low. A lthough HIV prevalence was low (0.2% in Rijeka and Zagreb, 0.3% in Split), H CV antibody prevalence was considerable (29.1% in Zagreb, 31.5% in Rijeka, 38.3% in Split). HIV and HCV testing coverage in the past 12 months was insufficient (Figure 2). Conclusions: We found a low-level HIV epidemic and a sizable HCV epide mic among PWID across all three cities. There is a need to develop a comprehensive approach to harm reduction and scale up the coverage with needles and syringes exchange progra mmes, OST and HIV and HCV testing services, as well as to strengthen sexual health interventions due to the presence of high-risk sexual behaviours. Figure 2: Weighted population estimates of age, gender, condom use, prevalence of HIV and HCV antibody and testing rates for HIV and HCV among people who inject drugs (PWID) in three largest Croatian cities, 2015. Figure 1. Recruitment chains in respondent-driven sampling (RDS) surveys in three largest Croatian cities, 2015; Green = HCV negative, Purple = HCV positive, White = unknown test result, S = initial respondent (seed) Rijeka; N=255Zagreb; N=176 Split; N=399 1. Handcock MS, Fellows IE, Gile KJ. RDS Analyst: Software for the Analysis of Respondent-Driven Sampling Data, Version 0.51. 2014. Available at http://hpmrg.org 2. Bastian M., Heymann S., Jacomy M. (2009). Gephi: an open source software for exploring and manipulating networks. International AAAI Conference on Weblogs and Social Media. Available at: https://gephi.org. 73,4% 15,0% 44,3% 6,8% 38,3% 7,0% 74,0% 8,0% 47,9% 20,2% 31,5% 21,5% 80,5% 22,3% 60,9% 13,2% 29,1% 13,5% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Male ≤24 years old Condom used at last sex with casual partner Tested for HIV in past 12 months and know the result HCV antibody Tested for HCV in past 12 months and know the result Split Rijeka Zagreb